Little is understood about the regulation of gene expression in human preimplantation embryos. We set out to examine the expression in human preimplantation embryos of a number of genes known to be critical for early development of the murine embryo. The expression profile of these genes was analysed throughout preimplantation development and in response to growth factor (GF) stimulation. Developmental expression of a number of genes was similar to that seen in murine embryos (OCT3B/4, CDX2, NANOG). However, GATA6 is expressed throughout preimplantation development in the human. Embryos were cultured in IGF-I, leukaemia inhibitory factor (LIF) or heparin-binding EGF-like growth factor (HBEGF), all of which are known to stimulate the development of human embryos. Our data show that culture in HBEGF and LIF appears to facilitate human embryo expression of a number of genes: ERBB4 (LIF) and LIFR and DSC2 (HBEGF) while in the presence of HBEGF no blastocysts expressed EOMES and when cultured with LIF only two out of nine blastocysts expressed TBN. These data improve our knowledge of the similarities between human and murine embryos and the influence of GFs on human embryo gene expression. Results from this study will improve the understanding of cell fate decisions in early human embryos, which has important implications for both IVF treatment and the derivation of human embryonic stem cells. Reproduction (2008) 135 635-647 
Introduction
The maintenance of cell pluripotency in the inner cell mass (ICM) of the blastocyst is essential for normal embryonic development and derivation of embryonic stem cells. In the early mouse embryo, we have a basic understanding of the roles of a number of genes in determining cell fate, but the same is not true for the human embryo. In particular, although it is known that human preimplantation embryos express OCT3B/4 (Abdel- Rahman et al. 1995 , Hansis et al. 2000 , Cauffman et al. 2005 , essential for the establishment and maintenance of a pluripotent ICM population (Buehr et al. 2003) , few data are available for many other genes involved in ICM pluripotency and differentiation, such as the OCT3B/4-binding partner SOX2, NANOG and FOXD3, genes that regulate ICM survival such as TBN (Voss et al. 2000) , or genes such as CDX2, HASH2 and EOMES that determine trophectoderm (TE) differentiation . Molecular analysis of human preimplantation embryos is fraught with difficulties, given their scarcity and the moral imperative for their judicious use. Several studies have been presented revealing gene expression patterns on pooled human oocytes using microarray (Zhang et al. 2007 ) by PCR and differential display (Goto et al. 2002) as well as PCR and SAGE (Neilson et al. 2000) . Only limited microarray data are available for the developing human embryo but Adjaye et al. (2005) managed to examine pooled separated human ICMs and TE, identifying the pluripotency associated genes NANOG, SOX2 and OCT3B/4 in the ICM, while Dobson et al. (2004) published microarray data on oocytes and cleavage stage embryos but did not focus on the genes investigated in this study.
Furthermore, little is understood about the influence of extrinsic factors on the expression of these genes. In many cell types, including preimplantation embryos and embryonic stem cells, development and differentiation can be regulated by peptide growth factors (GFs) and cytokines. In human embryos, blastocyst development and their attachment are stimulated by HBEGF (Martin et al. 1998 , Chobotova et al. 2002 , insulin-like GF-I (IGF-I; Lighten et al. 1998) and LIF (Dunglison et al. 1996) .
In the mouse, these have all also been shown to have important roles, including regulation of preimplantation development and implantation: HBEGF (Raab et al. 1996 , Paria et al. 1999 ; stimulation of embryo cell division, metabolism and apoptosis: IGF-I (Harvey & Kaye 1991 , Byrne et al. 2002 , Lighten et al. 1998 ; and regulation of cell pluripotency and implantation: LIF (Smith et al. 1988 , Stewart et al. 1992 , Kimber 2005 . However, the effect of such GFs on the ability of preimplantation embryos to express specific genes is little understood. In particular, their influence on transcription of genes regulating cell fate decisions has been little investigated in embryos of any species, and not at all in humans.
This lack of basic information has scientific and clinical implications for IVF treatment. Human IVF embryos show poor viability, with only an estimated 15-20% of embryos transferred in the UK resulting in a live baby (HFEA Guide to Infertility 2006/7). Human IVF embryo development is typically characterised by arrested, delayed and abnormal cell division and failure to reach the blastocyst stage. As a result, supplementation of IVF culture media with GFs has been suggested (Lighten et al. 1998 , Sjoblom et al. 2005 . However, this gives rise to safety concerns as overexpression of GFs such as IGF-I leads to abnormalities in development . GFs and cytokines have pleiotropic effects on the cell and clearly it is essential to understand the molecular mechanisms by which they alter cell fate before clinical trials of GF supplementation can be considered.
The aims of this study were to (i) characterise the expression pattern in preimplantation human embryos of key cell fate genes, including transcription factors, markers of pluripotency or differentiation, and receptors for key GFs and (ii) determine whether expression of these genes is affected by GFs known to have a role in regulating cell fate in mouse and human embryos. Using cDNA amplification to obtain maximum information from each single embryo, we aimed to obtain an informative molecular fingerprint of the preimplantation human embryo and identify potential mechanisms of GF-mediated regulation of cell fate.
Results

Developmental expression of cell fate genes in human embryos
We have previously established panels of cDNAs from single human preimplantation embryos: pronucleate (PN), two-cell, four-cell, eight-cell and blastocyst , Metcalfe et al. 2004 . In the present study, this archived developmental panel was probed for the expression of genes that regulate early cell fate decisions, in particular the establishment of ICM and TE cell lineages (Table 1) . Expression of b-ACTIN was used as the minimum inclusion criterion, so this gene is not included in the tables. Figure 1A is a representative ethidium bromide gel showing developmental expression of selected transcripts. The expression patterns of the genes can be characterised into those that are (a) expressed at the transcript level throughout the preimplantation period (constitutively; OCT3B/4, EIF4C, GATA6, TBN); (b) expressed following activation of the embryonic genome from the four-to eightcell onwards (NANOG, FOXD3, SOX2, ERBB4), or at the blastocyst stage (TEF4, CDX2), as well as initially from the maternal genome at the PN stage in the case of all but CDX2 and SOX2; (c) expressed sporadically (LIFR, EOMES) and (d) completely absent at the transcript level (HASH2, ERBB1; Table 1 ). Staining of blastocysts for OCT3B/4, SOX2 and NANOG protein is shown in Fig. 2 , and the data are summarised in Fig. 3 .
GF regulation of blastocyst gene expression
We went on to examine the expression of these cell fate genes in embryos cultured to the blastocyst stage for several days in GF-containing medium compared with embryos cultured concurrently in GF-free medium (Tables 2 and 3 ). Embryos were cultured in 4 ml drops of MediCult Universal IVF medium supplied GF free, or the same medium supplemented with either 1.7 nM IGF-I, 1000 IU/ml recombinant human LIF or 1 nM HBEGF. The proportion of embryos reaching blastocyst was w22% overall and did not appear to vary with GF supplementation. However, the aim of this study was not to derive quantitative data on development and the numbers of embryos involved were too small to allow any conclusions from this. Figure 1B is a representative ethidium bromide gel showing expression of selected transcripts in blastocysts grown in GF-containing medium. The majority of the genes examined were expressed at a similar frequency in the ten blastocysts cultured in non-supplemented control medium (Table 2) , compared with the three blastocysts in the developmental panel (also cultured in GF-free medium, Table 1 ); therefore data from all 13 blastocysts will be discussed together. Although OCT3B/4 is required for the maintenance of ICM pluripotency and was expressed in 12 out of 13 blastocysts examined, one blastocyst did not express this gene. OCT3B/4 protein could be detected in the nuclei of both ICM and TE (Fig. 2) . SOX2, which associates with OCT3B/4 and is an essential binding partner for it in the regulation of a number of genes, was expressed only in 5 out of 13 blastocysts, whereas NANOG was expressed in all but one blastocyst, and FOXD3 in 7 out of 13. SOX2 protein expression was also observed in nuclei of ICM and TE but NANOG protein was restricted to nuclei of the ICM (Fig. 2) . Notably, the expression of TBN, which is essential to murine ICM survival, was seen in only 6 out of 13 human blastocysts. TEF4 transcripts were detected in 10 out of 13 blastocysts. EIF4C, which is associated with translation initiation, was expressed in 12 out of 13 blastocysts. Expression of HASH2 and EOMES, both associated with TE fate, was detected in 4 out of 13 and 5 out of 13 blastocysts respectively. DCS2, a structural component of desmosomes, which are assembled in murine TE at the blastocyst stage, was expressed in only 5 out of 13 blastocysts. ERBB4 (HBEGF receptor) expression was observed in two out of the three blastocysts in the developmental panel (Table 1 ) but in only one of the ten GF control blastocysts (Table 2) . LIFR was detected in only one blastocyst, while expression of 
Expression of cell fate genes at the blastocyst stage
Included for consistency: published in Bloor et al. (2002) . ERBB1, the receptor for TGF-a and EGF, was not detected in any of the 13 blastocysts. Considering the 13 genes examined in both parts of the study, overall expression was slightly higher in the developmental panel blastocysts (Table 1 ; mean w7.7/14 genes expressed per blastocyst) compared with the GF control blastocysts (Tables 2 and 4; mean 7.2/13 genes expressed per blastocyst). Expression was quite consistent between blastocysts, with none expressing more than 10 out of the 14 genes, and only one fewer than five genes: blastocyst A of the GF control blastocysts (Table 2) , which expressed only three genes including OCT3B/4.
Gene expression after culture in HBEGF
After culture in HBEGF ( Fig. 1B; Table 3 ), 10 out of the 14 genes examined showed a very similar frequency of expression to that of the unsupplemented control blastocysts (Tables 1 and 2; data summarised in  Table 4 ), including ERBB1 (no expression), EIF4C (5/7 compared with 12/13 controls), TBN (4/7 compared with 6/13 controls), HASH2 (2/7 compared with 4/13 controls), OCT3B/4 (7/7 compared with 12/13 controls), SOX2 (3/7 compared with 5/13 controls), NANOG (7/7 compared with 12/13 controls), FOXD3 (4/7 compared with 7/13 controls) and CDX2 (6/7 compared with 11/13 controls) (Table 4) . ERBB4 was expressed at a similar frequency in HBEGF (4/7) as in the developmental panel (2/3; Table 1 ), but at a much greater frequency than in the unsupplemented control group where it could be detected in only one out of ten embryos (Table 2) .
However, for three genes, striking changes in blastocyst gene expression were observed in HBEGF (Table 3) compared with unsupplemented control blastocysts (Tables 1, 2 summarised in Table 4 ). First, DCS2 was expressed in 5 out of 7 blastocysts in HBEGF, compared with only 5 out of 13 of the unsupplemented controls (Table 4 ). This was also at greater frequency than the three out of nine of the blastocysts in LIF and two out of four in IGF-I. Secondly, in the presence of HBEGF, 6 out of 7 blastocysts expressed LIFR, compared with only 1 out of 13 of the unsupplemented controls and 1 out of 4 embryos in IGF-I. Finally, TEF4 was expressed by all blastocysts (7/7) in HBEGF, compared with only 10 out of 13 controls. Considering all 14 genes, HBEGF-cultured blastocysts expressed an average of 8.6 genes per embryo, compared with 7.2 in control blastocysts (Table 4) .
Gene expression after culture in LIF
After culture in LIF, most of the genes showed similar expression patterns to controls ( Fig. 1B ; Tables 1-3 and  data summarised in Table 4) , including OCT3B/4, SOX2, NANOG, FOXD3, EIF4C, HASH2, EOMES, TEF4 and DSC2. ERBB1 was again not expressed.
However, notable changes were observed in the expression of three genes. LIFR was expressed in 5 out of 9 LIF-cultured blastocysts compared with 1 out of 13 controls. ERBB4 was expressed in 6 out of 9 blastocysts in LIF, compared with 3 out of 13 controls. However, TBN was detected in only 2 out of 9 LIF-cultured blastocysts but in 6 out of the 13 unsupplemented blastocysts. Considering all 14 genes, LIF-cultured blastocysts expressed an average of 7.4 genes per embryo, compared with 7.2 in control blastocysts.
Gene expression after culture in IGF-I
When IGF-I was added to the medium (Table 3) , few obvious changes in the expression of the candidate genes were observed compared with controls (Tables 1  and 2 , data summarised in Table 4) . EOMES, ERBB4 and ERBB1 were notable by their lack of expression. HASH2 and DSC2 were expressed in only two out of four embryos, similar to the controls. All four embryos expressed NANOG and OCT3B/4 but only two out of four expressed SOX2. As with blastocysts cultured in HBEGF, embryos cultured in IGF-I all expressed TEF4 but this was not dissimilar to the 10 out of 13 unsupplemented control blastocysts. Three-quarters of the blastocysts expressed TBN, compared with 6 out of 13 controls and the 2 out of 9 embryos cultured in LIF. Considering all 14 genes, IGF-I-cultured blastocysts expressed an average of 8.0 genes per embryo, compared with 7.2 genes per control blastocyst.
Discussion
Although we have considerable knowledge of changes in gene expression patterns during preimplantation embryo development in the mouse, much less is known about these changes in the human. Several groups have attempted to address this by examining expression of various gene families including cell adhesion molecules , Ghassemifar et al. 2003 , components of the apoptotic cascade (Jurisicova & Acton 2004 , Metcalfe et al. 2004 , connexins , as well as the totipotency/pluripotency-related transcription factor OCT3B/4 (Hansis et al. 2000 , Huntriss et al. 2002 , Cauffman et al. 2005 and SOX2 (Adjaye et al. 2005) . Some more extensive studies of gene expression have been attempted, for instance Adjaye et al. (2005) compared expression of genes in pooled human ICMs and TE using microarray analysis while individual oocytes and early cleavage stages were subject to microarray by Dobson et al. (2004) .
GFs expressed by the reproductive tract or by the embryo itself (Schafer-Somi 2003) could exert paracrine Figure 3 Diagram indicating the stage-specific or constitutive expression of genes detected in this study and the effect of growth factors. Groups of genes in boxes are expressed at the underlying stage of human preimplantation development. GATA6, EIF4C and TBN show constitutive expression over the range of stages studied. HBEGF and LIF influence the number of blastocysts expressing LIFR and ERBB4, and HBEGF those expressing DSC2TBN and (negatively) EOMES. Table 2 Expression of genes in individual human blastocysts cultured in media lacking growth factors (non-supplemented controls): C/Kdenotes gene detected/not detected. Fig. 3 . We then examined whether the expression frequency of these genes changes in response to GF stimulation. Our original developmental panel of embryos were cultured in groups in 200 ml drops (Table 1) , while the later cultured embryos for the GF comparison (Tables 2 and 3) were cultured singly in 4 ml drops. Autocrine factors produced by human embryos may promote development, so this difference might contribute to changes in gene expression. However, when we compared the three blastocysts in the developmental series with the ten blastocysts controls for the GF panel, the particular genes expressed were similar and overall expression was very slightly higher in the former: mean w7.7/14 genes expressed per blastocyst, compared with the latter: mean 7.2/13 genes expressed per blastocyst. Thus, we could detect no obvious difference between the two culture protocols. Table 3 Expression of genes in individual human blastocysts cultured in media containing HBEGF, LIF and insulin-like growth factor-I (IGF-I): C/K denotes gene detected/not detected. Tables 1 and 2  Table 3  Table 3  Table 3 Gene OCT3B/4 12/13 7/7 7/9 4/4 SOX2 5/13 3/7 2/9 2/4 NANOG 12/13 7/7 9/9 4/4 FOXD3 7/13 4/7 5/9 2/4 TBN 6/13 4/7 2/9 3/4 TEF4 10/13 7/7 7/9 4/4 EIF4C 12/13 5/7 8/9 3/4 CDX2 11/13 6/7 6/9 3/4 HASH2 4/13 2/7 4/9 1/4 EOMES 5/13 0/7 3/9 0/4 DSC2 5/13 5/7 3/9 2/4 LIFR 1/13 6/7 5/9 4/4 ERBB4 3/13 4/7 6/9 0/4 Genes expressed/blastocyst 7.2 a 8.6 7.4 8 a 7.0 concurrent controls only, 7.2 including blastocysts from developmental series (Table 1) .
Developmental expression of genes
Expression of OCT3B/4, a marker of pluripotency expressed throughout murine and human preimplantation development (Rosner et al. 1990 , Palmieri et al. 1994 , Hansis et al. 2000 , Pesce & Scholer 2001 , was detected throughout development in our study as well. In mouse, it becomes restricted to the ICM (Palmieri et al. 1994 , Mitalipov et al. 2003 , while in the human, OCT3B/4 is also expressed in the TE (Hansis et al. 2000 and this study). However, nuclear expression of OCT3B/4 was stronger in ICM cells and a dosage effect is possible as seen in experimental studies in murine ES cells (Niwa et al. 2000) . Cytoplasmic expression may suggest a slow turnover of mRNA synthesised but not translocated to the nucleus to regulate gene function. Sox2 co-operates with Oct3b/4 in positively regulating Fgf4 (Ambrosetti et al. 2000) , Utf1 (Nishimoto et al. 1999) and Nanog (Kuroda et al. 2005 , Rodda et al. 2005 , as well as both Sox2 and Oct3b/4 themselves (Tomioka et al. 2002 , Okumura-Nakanishi et al. 2005 in mouse ES cells. The importance of this gene is suggested from a recent study indicating that OCT3B/4, SOX2 and NANOG together bind the promoter region and are assumed to regulate 353 genes in human ES cells (Boyer et al. 2005) .
In murine embryos, transcripts were detected first at the morula stage and then in the blastocyst ICM, however, protein was detected throughout preimplantation development (Avilion et al. 2003) . Human zygotic transcription is initiated around the early four-cell stage (Braude et al. 1988 ) when only very weak signals were detected for SOX2, except in one embryo, suggesting onset of SOX2 transcription around this time. At the eight-cell to blastocyst stage, two out of three of embryos were positive for SOX2 expression. It is possible that the numbers of expressing cells and hence the number of transcripts was below the level of detection in some embryos. Surprisingly, in our control series for the GF cultures, we were not able to pick up SOX2 transcripts in many OCT3B/4 and NANOG-positive blastocysts. Signals that normally maintain SOX2 expression may be missing in the GF-free medium or in microdrop culture. Protein expression in both human ICM and TE may reflect a later stage in development than in the murine blastocyst TE epithelium where SOX2 is found only in cytoplasm (M Keramari, J Razavi, KA Ingman, CM Ward & SJ Kimber, unpublished data) but later expressed in extraembryonic ectoderm (Avilion et al. 2003) . SOX2 transcripts were also detected in pooled human ICMs in another study (Adjaye et al. 2005) , but variation between embryos could not be assessed. In mouse embryos, it has been suggested that Sox2 mRNA expression is closely related to developmental potential (Li et al. 2005) . The crucial role for Sox2 in mouse embryonic stem (ES) cells is suggested to be the stabilisation of the pluripotent state by maintaining the required level of Oct4 expression (Masui et al. 2007 ).
The combination of four genes: Sox2, Oct4, c-myc and Klf4, allowed formation of pluripotent stem cells from mouse embryonic and adult fibroblasts . That SOX2 was one of the least consistently expressed genes examined suggests that it is susceptible to being misregulated as a result of genetic or environmental factors. The heterogeneity in expression of SOX2 in our embryo panel suggests that this gene should be investigated as a possible sensitive marker of developmental potential in the human.
NANOG is specifically expressed in pluripotent stem cells in both mouse and human (Chambers et al. 2003 , Mitsui et al. 2003 , Bhattacharya et al. 2004 , Richards et al. 2004 . Oct3b/4 and Nanog appear to act in concert to maintain self-renewing murine ES lines but it is now clear that transcription of Nanog is regulated directly by Oct3b/4/Sox2 (Kuroda et al. 2005 , Rodda et al. 2005 . NANOG mRNA inherited from the oocyte is present at the PN stage, and later, following activation of the embryonic genome, from the eight-cell stage onwards. This is earlier than that reported for mouse embryos (Chambers et al. 2003 , Mitsui et al. 2003 , which is intriguing in view of blastocyst formation occurring at a considerable range of cell numbers for human embryos in vitro. NANOG was expressed in all but one of the blastocysts studied and protein is restricted to ICM confirming a previous report of transcript expression in ICM but not TE (Adjaye et al. 2005) and consistent with an essential role in maintaining the pluripotent status of the human ICM.
Gata6 is expressed in the ICM of murine blastocysts and is essential for survival past the blastocyst stage (Koutsourakis et al. 1999) . Studies in murine ES cells suggest that Gata6 is an essential factor for formation of the primitive (extraembryonic) endoderm , and it has been suggested that expression of Gata6 leads to downregulation of Nanog and consequent commitment to primitive endoderm, while expression of Nanog results in downregulation of Gata6 and maintenance of the core ES cell population . GATA6 was constitutively expressed in preimplantation human embryos and any role during cleavage is undefined. Since NANOG mRNA is not expressed until the eight-cell stage, the opposing function of these two transcription factors could also operate in the human from the eight-cell to blastocyst stage but must be initiated by NANOG and not GATA6 expression.
FOXD3, a forkhead box winged helix transcription factor implicated in early cell fate decisions (Hanna et al. 2002) , is developmentally regulated, with expression from the eight-cell stage that assumes initiation from the human zygotic genome. This would be consistent with a role in the maintenance of the stem cell population in human as has been suggested from murine Foxd3 knockout data. Foxd3 null embryos die at d6.5 after implantation, and the epiblast is not maintained while the extraembryonic (Guo et al. 2002) . We examined both TEF4, which is implicated in transcriptional initiation and regulation in the murine embryo (Kaneko & DePamphilis 1998 ) and the translation initiation factor EIF4C (also called EIF1A). Although transcription of EIF4C in bovine and murine embryos is transiently initiated on activation of the zygotic genome (De Sousa et al. 1998 ), it appears to be constitutively expressed during human preimplantation development suggesting other factors may be rate limiting for translation of new mRNAs. Alternatively, quantitative changes in transcript or protein levels may regulate initiation of new translation. TEF4 was only expressed at the blastocyst stage, and in almost all blastocysts examined suggesting a role only from this stage in human, in contrast to mouse embryos. TBN is essential for the survival of the ICM in mouse embryos (Voss et al. 2000) . This gene was constitutively expressed throughout human preimplantation development but showed variable expression between blastocysts. By analogy with the mouse, this might be indicative of poor blastocyst viability. Expression of LIFR in pooled human embryos has been reported (Sharkey et al. 1995) , but our study suggests expression frequency is low during preimplantation development. Given the apparent stimulation of human embryo development by LIF (Dunglison et al. 1996) , this is surprising. However, the role of the LIF signalling pathway in early human development is uncertain as it is not sufficient to maintain pluripotency in human ES cells (Humphrey et al. 2004) .
Several genes implicated in TE differentiation were assessed including CDX2, EOMES and HASH2. Cdx2 is essential for development of murine trophoblast and in Cdx2 knockout mice, the TE epithelium fails to be maintained . Indeed in murine ES cells, forced expression of Cdx2 or downregulation of Oct3b/4 induces differentiation to TE . A reciprocal inhibition between Oct3b/4 and Cdx2 has been suggested to function in the divergence of the outer Cdx2-positive TE cells from the inner Oct3b/4-positive ICM stem cells. In the present study, almost all of the blastocysts cultured in unsupplemented media expressed CDX2 but no earlier stages, suggesting CDX2 is also a useful human TE marker. EOMES, expressed later by TE, showed a sporadic expression pattern in the developmental panel of embryos, being detected in one PN embryo, one out of four-cell and one out of eight-cell and in three of the unsupplemented GF control blastocysts. Although like CDX2, HASH2 expression was not observed in any of the three developmental panel blastocysts examined, transcripts were seen in four out of ten of the unsupplemented control blastocysts suggesting these blastocysts may have trophoblast stem cell potential. Intriguingly, with the exception of one blastocyst, when CDX2 is not expressed, HASH2 and EOMES are also not expressed. This is consistent with EOMES and HASH2 being downstream of CDX2 in human trophoblast development, as in mouse (Cross 2000) . The lack of expression of HASH2 and EOMES in the blastocysts from the developmental panel may suggest these are at an earlier developmental stage than some of those in unsupplemented medium, which express these TE development genes. Interestingly, HAND1 that regulates giant cell differentiation in mice was expressed from the four-cell in human (Knofler et al. 2002) .
Although ERBB4, the receptor for HBEGF, was expressed from the eight-cell stage onwards, expression in blastocysts was sporadic. ERBB4 protein expression in human blastocysts is important in initial attachment to the luminal epithelium (Chobotova et al. 2002) as has also been suggested in the murine embryo (Raab et al. 1996) . ERBB1, the receptor for TGF-a and EGF, was not detected at any stage of preimplantation development nor in response to the three GFs in agreement with others (Chobotova et al. 2002) .
GF regulation of genes
HBEGF is associated with improved human preimplantation development (Martin et al. 1998 ) and our data suggest that it may act, in part by influencing expression of genes such as LIFR, DSC2 and ERBB4. HBEGF exposed blastocysts expressed our panel of genes more frequently than control embryos or those cultured in LIF or IGF-I. The major effect of HBEGF appears to be on TE. HBEGF enhanced the number of embryos that express DSC2 compared with control and LIF-treated embryos. DSC2 is the rate-limiting protein whose presence promotes desmosome assembly in mature murine TE and has been suggested to function similarly in human , Ghassemifar et al. 2003 , HBEGF may influence maturation of the TE epithelium. By contrast, CDX2 is expressed in the absence of HBEGF and this GF had no effect on the frequency of expression of EOMES or HASH2 either, suggesting that it influences genes regulating the epithelial phenotype rather than those involved in specification. Indeed, it appears that HBEGF may have a negative effect on EOMES expression as this gene was not expressed in any blastocyst cultured with HBEGF. ERBB4, the receptor for HBEGF, was expressed sporadically in the absence of GFs, but in the majority of blastocysts exposed to HBEGF or LIF. LIFR transcripts, on the other hand, could be detected rarely (one blastocyst) in the absence of GFs but in all blastocysts (bar one) exposed to HBEGF. This confirms the potentially important role of HBEGF in regulating embryonic cells via its own and the LIF signalling pathways and that HBEGF may enhance the embryonic response to LIF. The reciprocal stimulation of expression of ERBB4 by LIF, and LIFR by HBEGF, suggests that in vivo when embryos are exposed to the full repertoire of GFs, both of these pathways will be active. Moreover, if the LIF signalling pathway is important in regulating human embryo development (Dunglison et al. 1996) , it may be that expression of LIFR in utero is normally induced by external factors, e.g. by HBEGF. At the same time, HBEGF stimulates murine TE differentiation (Das et al. 1994 , Wang et al. 2000 and human blastocyst expansion (Chobotova et al. 2002) . The protein is mobilised to the cell surface of murine blastocysts by lysophosphatidic acid that accelerates differentiation by transactivation of Erbb1 and Erbb4 (Liu & Armant 2004) .
Although frequency of expression of most genes were unaffected by LIF, several notable changes were observed. ERBB4 was expressed in few unsupplemented blastocysts (and none of those cultured with IGF-I) but in six out of nine cultured in LIF. Therefore, our data suggest that LIF might promote blastocyst attachment and implantation through facilitating upregulation of embryonic ERBB4, a previously unrecognised role of embryonic LIF signalling, unconnected with pluripotency. The absence of detectable LIFR transcripts in all but one control embryo is in contrast to its expression in five out of nine LIF-cultured embryos suggesting low constitutive levels of maternal LIFR protein and autoregulation.
This work has utilised archival embryo cDNA together with a new cDNA panel from GF-cultured embryos to document developmental expression of key genes associated with embryonic cell behaviour and fate. In addition, although the numbers of embryos available for experimental purposes were by necessity limited, we believe that our data demonstrate for the first time evidence of mechanisms by which GFs may alter human embryo cell fate and stimulate developmental potential. Embryos that do not express particular genes in response to a particular GF may be at the incorrect developmental stage to be able to respond appropriately, or may be deficient in the receptor or downstream signalling pathways. In general, LIF and HBEGF appear to have a positive influence mainly on transcripts for structural or receptor genes involved in TE maturation and function. This is consistent with GF regulation of human embryo development at least in part by the stimulation of gene transcription and suggests areas for future investigation, such as cross talk between different GF pathways. It provides a developmental baseline from which to launch and interpret studies examining GF-regulated pathways in human ES cells and to determine which GFs could be used to improve clinical IVF treatment. Since some commercially available embryo culture media already contain GFs and others are currently under clinical trial, there is an urgent need to understand the basis of their influence on the human embryo.
Materials and Methods
All reagents were purchased from Sigma, unless otherwise stated.
Embryos
Human embryos were donated to research after patient consent, with approval of local ethics committees and the UK Human Fertilisation and Embryology Authority (Research licences R0026 and R0067). Embryos were obtained from IVF units at St Mary's Hospital, Manchester; Manchester Fertility Services, Manchester (from frozen embryos surplus to IVF requirement for the developmental series, Table 1 ; Fig. 1 ) and Leeds General Infirmary, Leeds (fresh embryos for the GF studies, Tables 2 and 3), as in our previous studies , Metcalfe et al. 2003 . Embryos were cultured to various developmental stages in 200 ml drops of MediCult Universal IVF medium (MediCult UK Ltd, Redhill, Surrey, UK) for the data in Table 1 and Fig. 1 . Alternatively, they were cultured in 4 ml drops of optimised embryo culture medium developed at the University of York (Houghton et al. 2002 for the data in Tables 2 and 3 , either in the absence of any GFs or cytokines (control; MediCult Universal IVF medium supplied GF free) or in the presence of 1.7 nM IGF-I, 1000 IU/ml recombinant human LIF or 1 nM HBEGF. Embryos were cultured in GFs or control medium from the four-to eight-cell stage on days 2-3 of development, to the blastocyst stage on day 5 or 6.
cDNAs from three embryos at each stage of development were probed for gene expression, as described by Bloor et al. (2002) . Early cleavage stage embryos were of the highest possible quality since they were cultured from unselected frozen PN stage embryos. All the PN, two-cell and four-cell embryos were from pregnant cycles (i.e. had sibling embryos that developed to term). One out of the eight-cell embryos was from a pregnant cycle, while the two other eight-cell embryos were siblings from a cycle that did not result in pregnancy. However, the donating parents later achieved a spontaneous pregnancy. Polypronucleate embryos were not used in this study (Houghton et al. 2002) .
Lysis, 3
0 cDNA generation and 28 amplification (polyA PCR) Embryo lysis, cDNA generation and subsequent 28 amplification was performed as reported by Bloor et al. (2002) and adapted from Brady & Iscove (1993) , Nunez et al. (2000) and has been extensively validated (Brady et al. 1995 , Al-Taher et al. 2000 , Iscove et al. 2002 . The technique utilises a limited RT step to restrict the first strand to around 500-600 bases at the 3 0 end. This is followed by dt tailing and amplification of the 500-600 bp duplexes. PCR amplification of the polyA-tailed cDNA is then carried out as described previously , Metcalfe et al. 2004 . Because of the restricted RT step, the amplified product does not suffer from the bias against long or rare transcripts inherent in full-length amplification schedules.
Controls at each step included embryos lysed and subjected to the amplification protocol without reverse transcriptase (RT negatives) and no embryo. Human RNA from a variety of tissues Gene expression in early human embryos (Human total RNA master panel II; BD Biosciences, Oxford, UK) was amplified using the same protocol to produce positive control cDNA. Negative and positive control samples were probed for the presence of target genes in tandem with test samples.
Normalisation of amplified cDNA
Serial dilutions of secondary amplification products were prepared and used as templates in a PCR to amplify b-ACTIN as in Bloor et al. (2002) . b-ACTIN has been shown previously by us to be a good reference gene for human embryos and more recently by Willems et al. (2006) in the murine embryo in a different context.
Gene-specific PCR
Primers were designed to amplify target genes in 500 bp immediately preceding the polyadenylation signal. Primers were designed using PRIMER version 0.5 (Copyright 1991, Whitehead Institute for Biomedical Research, www.bioinformatics.nl/cgibin/primer3plus/primer3plus.cgi). Primer sequences (Invitrogen) used are shown in Table 5 . Target gene amplification was performed exactly as described in Bloor et al. (2002) . Absence of a gene was verified by amplification up to 50 cycles. Amplification products were partially sequenced as reported previously . All samples were probed for the expression of b-ACTIN; this was a minimum entry criterion for inclusion in the study. Approximately 10% of embryo samples did not express b-ACTIN and were discarded with no further analysis.
Method of analysis
Because of the scarcity of the human embryo material, we opted for aC or K scoring system indicating that signal was or was not detected after 40 cycles of PCR with gene-specific primers. Absence of signal after 40 cycles of amplification indicates that the gene is very unlikely to be expressed and, not withstanding carryover of maternal protein, may not be important at the stage indicated. Presence of definitive signal is indicative of gene expression, with potential translation and function. If expressed in rare cases (say one or two out of six blastocysts), we would conclude that this gene is not normally expressed and the presence of transcript may reflect a somewhat advanced developmental state (particularly for genes expressed normally at the late blastocyst) or as a result of a particular genetic state or environmental cue during the culture. An example of such an environmental cue might include stimulation by GFs present in the culture medium (see the Discussion section). If a gene is almost always detected except in a few blastocysts (say one in six or so), we would conclude that this gene is normally expressed, may play a function at the time analysed and that embryos that do not express may be deficient in some way.
Immunocytochemistry
PFA-fixed embryos were washed through PBS supplemented with 4 mg /ml IgG-free BSA (PBS/BSA; Stratech, Suffolk, UK). Embryos were permeabilised in 0.01% Triton X-100 in PBS/BSA for 5 min, washed and transferred to a 25 ml drop of primary antibody for 1 h under oil (anti-OCT3B/4: mouse monoclonal, BD 1:250 dilution: SOX2: rabbit polyclonal, Abcam 1:500 dilution; anti-NANOG: Goat IgG, RCD 1: 10 dilution). Rabbit antibodies were pre-adsorbed with keratin prior to use (Kimber et al. 1994) . Embryos were washed and incubated in an appropriate secondary antibody (Molecular Probes, Invitrogen) and after further washing mounted in VECTASHIELD-containing 4,6-diaminidino-2-phenylindole hydrochloride (DAPI; Vector Labs, Peterborough, UK) prior to visualisation by confocal microscopy. Controls were incubated with normal rabbit serum or mouse IgG in place of primary antibodies. Test and control images were collected using identical confocal settings and manipulated identically.
